Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kidpik | PIK | Apr 24, 2024 | 4.17 | -1.65 |
Kilroy Realty | KRC | Apr 24, 2024 | 33.71 | -0.06 |
Kimball Electronics | KE | Apr 24, 2024 | 20.96 | -0.57 |
Kimbell Royalty Partners LP Units | KRP | Apr 24, 2024 | 15.95 | -0.37 |
Kimberly-Clark | KMB | Apr 24, 2024 | 137.78 | +1.28 |
Kimco Realty | KIM | Apr 24, 2024 | 18.53 | -0.54 |
Kimco Realty L Pref | KIM-L | Apr 24, 2024 | 22.02 | +0.23 |
Kimco Realty M Pref | KIM-M | Apr 24, 2024 | 22.79 | +0.13 |
Kimco Realty Pref ADR | KIM-N | Apr 24, 2024 | 54.75 | 0.00 |
Kinder Morgan | KMI | Apr 24, 2024 | 18.81 | +0.27 |
Kineta | KA | Apr 24, 2024 | 0.62 | -7.44 |
Kinetik A | KNTK | Apr 24, 2024 | 39.19 | +1.63 |
Kingsoft Cloud ADR | KC | Apr 24, 2024 | 2.90 | +2.47 |
Kingstone Companies | KINS | Apr 24, 2024 | 4.20 | -0.12 |
Kingsway Financial Services | KFS | Apr 24, 2024 | 8.70 | -1.14 |
Kiniksa Pharmaceuticals A | KNSA | Apr 24, 2024 | 17.86 | +1.02 |
Kinnate Biopharma | KNTE | Apr 24, 2024 | 2.65 | 0.00 |
Kinross Gold | KGC | Apr 24, 2024 | 6.60 | +0.61 |
Kinsale Capital Group | KNSL | Apr 24, 2024 | 458.59 | -1.24 |
Kintara Therapeutics | KTRA | Apr 24, 2024 | 0.14 | +3.47 |
Kiora Pharmaceuticals | KPRX | Apr 24, 2024 | 0.51 | -12.72 |
Kirby | KEX | Apr 24, 2024 | 101.05 | -0.87 |
Kirklands | KIRK | Apr 24, 2024 | 1.98 | -12.78 |
Kite Realty Group Trust | KRG | Apr 24, 2024 | 21.72 | +0.14 |
KKR & Co | KKR | Apr 24, 2024 | 96.77 | -1.22 |
KKR Income Opportunities Fund | KIO | Apr 24, 2024 | 13.30 | -0.30 |
KKR Real Estate Finance Trust | KREF | Apr 24, 2024 | 9.78 | -2.40 |
KKR Real Estate Finance Trust A Pref | KREF-A | Apr 24, 2024 | 18.60 | +0.43 |
KLA | KLAC | Apr 24, 2024 | 656.54 | +1.29 |
Klaviyo | KVYO | Apr 24, 2024 | 22.89 | -2.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.